Filing Manager
M33 Growth I L.P.
Reporting Manager
M33 Growth I LP
Symbol
DFPH
Shares outstanding
124,590,769 shares
Disclosed Ownership
6,802,656 shares
Ownership
5.5%
Form type
SCHEDULE 13D/A
Filing time
20 Nov 2025, 16:01:02 UTC
Date of event
18 Nov 2025
Previous filing
05 Sep 2025

Key filing fact

M33 Growth I L.P. disclosed 5.5% ownership in Oncology Institute, Inc. Common Stock, par value $0.0001 per share (DFPH) on 18 Nov 2025.

Key facts

  • M33 Growth I L.P. filed SCHEDULE 13D/A for Oncology Institute, Inc. Common Stock, par value $0.0001 per share (DFPH).
  • Disclosed ownership: 5.5%.
  • Date of event: 18 Nov 2025.

Change

  • Previous schedule filing date: 05 Sep 2025.
  • Current filing was accepted on 20 Nov 2025, 16:01.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (3)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
M33 Growth I LP 5.5% 6,802,656 0 6,802,656 /s/ Gabriel Ling Gabriel Ling / Managing Member 0001718621
M33 Growth I GP LLC 5.5% 6,802,656 0 6,802,656 /s/ Gabriel Ling Gabriel Ling / Managing Member 0001894303
TOI M, LLC 0% 0 0 0 /s/ Gabriel Ling Gabriel Ling / Managing Member 0001892968
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .